Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Congress. "Biosimilar User Fee Amendments of 2017". Government. U.S. Government Publishing Office, December 29, 2022. https://www.govinfo.gov/app/details/COMPS-15234
Congress. (2022, December 29). Biosimilar User Fee Amendments of 2017. [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/COMPS-15234
Congress. Biosimilar User Fee Amendments of 2017. U.S. Government Publishing Office, (29 Dec 2022), https://www.govinfo.gov/app/details/COMPS-15234
Congress, To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes., GovInfo, (December 29, 2022), https://www.govinfo.gov/app/details/COMPS-15234